Clinical Trials for Immodulon Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Immodulon Therapeutics

Clinical Trials (2)

NCT05118724
Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin
PHASE2Active, not recruiting
80 participants
Started: Dec 10, 2021 · Completed: Apr 30, 2027
1 condition3 sponsors1 location
NCT04442048
Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure
PHASE3Active, not recruiting
195 participants
Started: Oct 1, 2020 · Completed: Dec 31, 2025
2 conditions7 sponsors8 locations